( MENAFN - GlobeNewsWire - Nasdaq) Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Veterinary Drug Approval Process and FDA Regulatory Guidance" seminar has been added to ResearchAndMarkets's offering. This two-day interactive seminar online will provide attendees with an understanding of the FDA's veterinary drug approval process in 2024. The U.
S. Food and Drug Administration's Center for Veterinary medicine (CVM) is responsible for the approval of veterinary drug products intended for family pets, food-producing animals, and other animal species. This seminar will cover the process for obtaining federal government approval for marketing new animal drug products that are under the jurisdiction of the FDA, and also briefly covers animal products that are regulated by other federal agencies.
For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture, and some flea and tick control products are regulated by the Environmental Protection Agency.
The group size is small, generally between 8 and 10 people, with plenty of opportunities to ask questions and discuss issues or challenges that the attendees have experienced. Course Highlights : 4 New Guidance Documents published by the FDA will also be discussed: Learning Objectives: Key goals of the seminar will include learning: RAPS - This course has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification up.
